Evidence map›Paper›PMID 37601838›Full record

ArticleEJHaem2023

Serum D-2-hydroxyglutarate and the ratio of D-2HG/L-2HG predict

Chelsea Zhang, Andrew Chu, Richard Boriack, Robert Collins, Jing Xu, Dwight Oliver, Ruifang Zheng, Dinesh Rakheja, Weina Chen

Open access · diamondAbstract read
In one paragraph

Article in EJHaem, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Chelsea ZhangDepartments of Pathology University of Texas Southwestern Medical Center Dallas Texas USA.
Andrew ChuDepartments of Pathology University of Texas Southwestern Medical Center Dallas Texas USA.
Richard BoriackChildren's Medical Center Dallas Dallas Texas USA.
Robert CollinsInternal Medicine (Hematology and Oncology) University of Texas Southwestern Medical Center Dallas Texas USA.
Jing XuDepartments of Pathology University of Texas Southwestern Medical Center Dallas Texas USA.
Dwight OliverDepartments of Pathology University of Texas Southwestern Medical Center Dallas Texas USA.
Ruifang ZhengDepartments of Pathology University of Texas Southwestern Medical Center Dallas Texas USA.
Dinesh RakhejaDepartments of Pathology University of Texas Southwestern Medical Center Dallas Texas USA.
Weina ChenDepartments of Pathology University of Texas Southwestern Medical Center Dallas Texas USA.ORCID https://orcid.org/0000-0001-5638-4371
The University of Texas Southwestern Medical Center · USChildren's Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigates whether serum D-2HG (D-2-hydroxyglutarate) produced by the mutated isocitrate dehydrogenase (IDH) can predict

Indexed as

acute myeloid leukemiaD‐2HG/L‐2HG RatioD‐2‐HydroxyglutarateIDHL‐2‐Hydroxyglutarate

Identifiers

PMID37601838
PMCPMC10435681
OpenAlexW4381436049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.